相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Primary Cervical Malignant Melanoma: 2 Cases and a Literature Review
Can Yin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
Precision immunoprofiling by image analysis and artificial intelligence
Viktor H. Koelzer et al.
VIRCHOWS ARCHIV (2019)
BRAF mutations might be more common than supposed in vulvar melanomas
Sophie Wylomanski et al.
EXPERIMENTAL DERMATOLOGY (2018)
Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer
Toshiaki Saito et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?
G. Quereux et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
Liang Cheng et al.
MODERN PATHOLOGY (2018)
Melanoma of the lower genital tract: Prognostic factors and treatment modalities
Angiolo Gadducci et al.
GYNECOLOGIC ONCOLOGY (2018)
Prognostic rote of tumoral PDL1 expression and peritumoral FoxP3+lymphocytes in vulvar melanomas
Agata Chlopik et al.
HUMAN PATHOLOGY (2018)
Assessment of programmed cell death ligand-1 expression by 4 diagnostic assays and its clinicopathological correlation in a large cohort of surgical resected non-small cell lung carcinoma
Anthony W. H. Chan et al.
MODERN PATHOLOGY (2018)
Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma
June Y. Hou et al.
CANCER (2017)
Gynecologic melanomas: A clinicopathologic and molecular analysis
Aaron M. Udager et al.
GYNECOLOGIC ONCOLOGY (2017)
Treatment of Genital Melanoma Are We Ready for Innovative Therapies?
Antonino Ditto et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis
Sandra P. D'Angelo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Immune checkpoint inhibitors in malignancies with mismatch repair deficiency: a review of the state of the current knowledge
Ali Naboush et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2017)
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
Fred R. Hirsch et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Melanoma subtypes demonstrate distinct PD-L1 expression profiles
Genevieve J. Kaunitz et al.
LABORATORY INVESTIGATION (2017)
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
J. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
Joel C. Sunshine et al.
CLINICAL CANCER RESEARCH (2017)
A Novel Numerical Scoring System for Melanoma Tumor-infiltrating Lymphocytes Has Better Prognostic Value Than Standard Scoring
Gerald Saldanha et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Programmed Death Ligand-1 Immunohistochemistry Friend or Foe?
Keith M. Kerr et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
The Efficacy of Anti-PD-1 Agents in Acral and Mucosal Melanoma
Alexander N. Shoushtari et al.
CANCER (2016)
p.(L576P) -KIT mutation in GIST: Favorable prognosis and sensitive to imatinib?
Jonathan Noujaim et al.
CANCER BIOLOGY & THERAPY (2016)
Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma
Adil I. Daud et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Surgical Management and Prognostic Factors of Vulvovaginal Melanoma
Antonino Ditto et al.
Journal of Lower Genital Tract Disease (2016)
Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature
Muhammad Ahmed Farooq Anwar et al.
JOURNAL OF SURGICAL RESEARCH (2016)
Microsatellite instability in melanoma: a comprehensive review
Ondrej Kubecek et al.
MELANOMA RESEARCH (2016)
Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract
Maria B. Schiavone et al.
GYNECOLOGIC ONCOLOGY REPORTS (2016)
Classifying Cancers Based on T-cell Infiltration and PD-L1
Michele W. L. Teng et al.
CANCER RESEARCH (2015)
Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites
Harriet M. Kluger et al.
CLINICAL CANCER RESEARCH (2015)
PD-1/PD-L1 inhibitors
Joel Sunshine et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway
A. Hunter Shain et al.
NATURE GENETICS (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antagonists of PD-1 and PD-L1 in Cancer Treatment
Evan J. Lipson et al.
SEMINARS IN ONCOLOGY (2015)
Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)
Gianluca Spitaleri et al.
OncoTargets and Therapy (2015)
Low Mutational Burden of Eight Genes Involved in the MAPK/ERK, PI3K/AKT, and GNAQ/11 Pathways in Female Genital Tract Primary Melanomas
Kalliopi I. Pappa et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Melanoma
Dirk Schadendorf et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Melanoma of the Vulva and Vagina: Principles of Staging and Their Relevance to Management Based on a Clinicopathologic Analysis of 85 Cases
Susan Seifried et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
High Expression of the Mismatch Repair Protein MSH6 Is Associated With Poor Patient Survival in Melanoma
Ester Alvino et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract-A study of 24 cases from the Netherlands
Adriana C. H. van Engen-van Grunsven et al.
GYNECOLOGIC ONCOLOGY (2014)
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Vulvovaginal Melanomas
Mario M. Leitao et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma
Michelle V. Pearlstein et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2014)
Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract
Diane Tseng et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Comparison of molecular abnormalities in vulvar and vaginal melanomas
Sebastian Aulmann et al.
MODERN PATHOLOGY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Extracutaneous melanoma epidemiology in British Columbia
Marius L. Haiducu et al.
MELANOMA RESEARCH (2014)
Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
Zachary A. Cooper et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma
Georgina V. Long et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations
Joshua R. Bradish et al.
FUTURE ONCOLOGY (2013)
Vulvar and vaginal melanoma: Case series and review of current management options including neoadjuvant chemotherapy
Jo Marie Tran Janco et al.
GYNECOLOGIC ONCOLOGY (2013)
Vulvar/Vaginal Melanoma An Updated Surveillance Epidemiology and End Results Database Review, Comparison With Cutaneous Melanoma and Significance of Racial Disparities
Ismail Mert et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
A large retrospective multicenter study of vaginal melanomas: implications for new management
Charlotte Vaysse et al.
MELANOMA RESEARCH (2013)
Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline
Sandra L. Wong et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2012
Claus Garbe et al.
EUROPEAN JOURNAL OF CANCER (2012)
Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
Farhad Azimi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinicopathologic study of 85 cases of melanoma of the female genitalia
Win J. Tcheung et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Wolf Herman Fridman et al.
CANCER RESEARCH (2011)
Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma
Yan Kong et al.
CLINICAL CANCER RESEARCH (2011)
B-Raf Mutations, Microsatellite Instability and p53 Protein Expression in Sporadic Basal Cell Carcinomas
Angeliki Stamatelli et al.
PATHOLOGY & ONCOLOGY RESEARCH (2011)
Molecular and Clinicopathologic Characterization of Gastrointestinal Stromal Tumors (GISTs) of Small Size
Sabrina Rossi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Tumor Cell Expression of Programmed Cell Death-1 Ligand 1 Is a Prognostic Factor for Malignant Melanoma
Ryosuke Hino et al.
CANCER (2010)
Primary Malignant Melanoma of the Vagina
Michael Frumovitz et al.
OBSTETRICS AND GYNECOLOGY (2010)
KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients
Ketan S. Gajiwala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor
Toshirou Nishida et al.
CANCER SCIENCE (2008)
Metastatic Malignant Melanoma of the Uterine Cervix: First Diagnosed on Liquid-Based Cytology
Nueket Uezuem et al.
DIAGNOSTIC CYTOPATHOLOGY (2008)
Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma
Danielle Castiglia et al.
GENES CHROMOSOMES & CANCER (2008)
Management of primary melanoma of the female urogenital tract
Benjamin Piura
LANCET ONCOLOGY (2008)
Vulvar melanoma - A multivariable analysis of 644 patients
Valerie E. Sugiyama et al.
OBSTETRICS AND GYNECOLOGY (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Resistance to c-KIT kinase inhibitors conferred by V654A mutation
Kathryn G. Roberts et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs
CW Wong et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma
MS Harting et al.
MELANOMA RESEARCH (2004)
Primary vaginal melanoma: A critical analysis of therapy
TJ Miner et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases
G Palmieri et al.
MELANOMA RESEARCH (2003)
Vaginal melanoma - A clinicopathologic and immunohistochemical study of 26 cases
D Gupta et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Primary malignant melanoma of the uterine cervix: Report of a case diagnosed by cervical scrape cytology and review of the literature
AH Deshpande et al.
DIAGNOSTIC CYTOPATHOLOGY (2001)
分享论文
